The significantly lower-than-expected revenues of Invisalign clear aligners and iTero scanners during the first quarter due to the COVID-19 pandemic outbreak resulted in such a lackluster bottom line.The Zacks Consensus Estimate for ViewRayâ€™s first-quarter 2020 bottom line stands at a loss of 20 cents per share, suggesting 41.2% improvement from the year-ago quarter.